Skip to content

The Effect of Cold Application on Pain Developed Due to Drain Removal in Patients With Kidney Transplantation

Investigation of the Effect of Cold Application on Pain Caused by Jackson Pratt Drain Removal in Patients With Kidney Transplantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05972811
Enrollment
76
Registered
2023-08-02
Start date
2023-09-01
Completion date
2024-04-01
Last updated
2023-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Pain Management, Kidney Transplantation, Drainage, Cryotherapy

Brief summary

The study was planned as a prospective, randomized controlled study to examine the effect of cold application on pain due to Jackson Pratt drain removal in kidney transplant patients.

Detailed description

During kidney transplant surgery, a Jackson Pratt Drain (JP) is placed in the surgical field to monitor lymphocele and urinary leakage. This drain is a closed system that opens outward from the skin at a point close to the incision line. This drain is removed by pulling when the drainage amount falls below 30 ml. This procedure is known to cause serious pain. In our study, which was planned as a prospective, randomized controlled study, it was aimed to examine the effect of cold application in the pain caused by the removal of the JP drain in patients with kidney transplantation. The population of the study will be patients who had a kidney transplant in İstinye University Hospital Liv Hospital Organ Transplant Center (n=76). In the study, patients will be assigned to the experimental and control groups by the block randomization method. Patient Information Form and Visual Analog Scale (VAS) will be used as data collection tools. In the experimental group, cold application will be made until the skin temperature of the drain exit area reaches 13.6 °C. Then, the drain removal process will be performed by the physician. In the control group, no application will be made. In both study groups before drain removal, immediately after drain removal and 15 minutes later, pain levels will be measured with VAS and analgesic needs will be questioned. Chi-square and t-tests will be used to compare demographic data in the analysis process of the data. ANOVA test will be applied to compare pain scores between groups.

Interventions

OTHERCold application

In the experimental group, cold application will be made until the skin temperature of the drain exit area reaches 13.6 °C. And before drain removal, immediately after drain removal and 15 minutes later, pain levels will be measured with VAS and analgesic needs will be questioned

Sponsors

Karadeniz Technical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Masking description

The application will be made by the researcher. However, pain assessment will be done by the nurse who cares for the patient.

Intervention model description

Prospective, parallel randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Being between the ages of 18-65, * Being conscious, oriented to person, place and time, * No history of mental pathology, * No history of drug or alcohol use, * Having a body mass index of \<30 kg/m2, * Not using any analgesic or sedative medication one hour before drain removal.

Exclusion criteria

* IV analgesic or sedative treatment during cold application, * Having a history of chronic pain, * Having previous drain removal experience, * Anxiety, * Refusal to participate in the research, * Unstable hemodynamic status.

Design outcomes

Primary

MeasureTime frameDescription
Pain evaluated using the Visual Analog Scale (VAS)Pain measurement will be made with VAS just before drain removal, immediately after drain removal, and 15 minutes later.According to this scale, 0 indicates no pain, 1-4 indicates mild pain, 5-6 indicates moderate pain, and 7-10 indicates severe pain.

Countries

Turkey (Türkiye)

Contacts

Primary ContactUfuk AKKURT, Master
akkurt8385@gmail.com+905462347351

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026